Announcement on Initial Repurchase of Shares through Call Auction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Initial Repurchase of Shares through Call Auction
Filed with SSE · Stock code 688578 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shanghai Allist Pharmaceuticals Co. Ltd. on 6ix
Story so far
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress of the Pivotal Clinical Trial of Furmonertinib for First-line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
Earlier from Shanghai Allist Pharmaceuticals
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Share Repurchase Plan through Call Auction
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 3rd Board of Directors
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Proposal by the Actual Controller, Chairman and General Manager to Repurchase Company Shares
- (688578)"SHANGHAI ALLIST PHARMACEUTICALS CO., LTD."Announcement on Progress of the Pivotal Clinical Trial of Furmonertinib for First-line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
- Announcement on Voluntary Disclosure of the Acceptance of Marketing Application for a New Indication of Furmonertinib Mesilate Tablets
Later from Shanghai Allist Pharmaceuticals
All Shanghai Allist Pharmaceuticals news releasesFollow Shanghai Allist Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Allist Pharmaceuticals